The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 16, 2018

Filed:

May. 07, 2014
Applicant:

Kyungpook National University Industry—academic Cooperation Foundation, Daegu, KR;

Inventors:

Jae Sung Bae, Daegu, KR;

Hee Kyung Jin, Daegu, KR;

Min Hee Park, Gyeongsan-si, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); G01N 33/559 (2006.01); G01N 33/561 (2006.01); G01N 33/573 (2006.01); A61K 31/137 (2006.01); C07K 16/18 (2006.01); A01K 67/027 (2006.01); C12N 15/113 (2010.01); C12Q 1/6883 (2018.01); G01N 33/50 (2006.01); G01N 33/68 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/137 (2013.01); A01K 67/0275 (2013.01); C07K 16/18 (2013.01); C12N 15/1137 (2013.01); C12Q 1/6883 (2013.01); G01N 33/5023 (2013.01); G01N 33/53 (2013.01); G01N 33/559 (2013.01); G01N 33/561 (2013.01); G01N 33/573 (2013.01); A01K 2217/15 (2013.01); A01K 2227/105 (2013.01); A01K 2267/0312 (2013.01); A61K 48/005 (2013.01); C12N 2320/30 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/158 (2013.01); C12Y 301/04012 (2013.01); G01N 33/6896 (2013.01); G01N 2333/916 (2013.01); G01N 2800/28 (2013.01); G01N 2800/50 (2013.01); G01N 2800/52 (2013.01);
Abstract

The present invention relates to a composition comprising an ASM inhibitor as an active ingredient for preventing or treating degenerative neurological diseases. According to the present invention, when ASM is partially removed in an Alzheimer's disease model mouse, that is when ASM is inhibited therein, such when as an Alzheimer's disease model mouse with a partial removal of ASM is in a parabionic union with an Alzheimer's disease model mouse, or when an Alzheimer's disease model mouse is injected with the serum of an Alzheimer's disease model mouse from which ASM gene has been removed, the deposition of β-amyloid in the brain tissue is inhibited and the ability to learn and remember are improved, and the present invention confirms such superb effects. Accordingly, ASM inhibitor can be effectively used to prevent or treat degenerative neurological diseases.


Find Patent Forward Citations

Loading…